99 related articles for article (PubMed ID: 24360367)
1. [Integration to school of young children with type 1 diabetes on insulin pump therapy: parent's feed-back].
Crosnier H; Tubiana-Rufi N
Arch Pediatr; 2013 Dec; 20 Suppl 4():S149-56. PubMed ID: 24360367
[TBL] [Abstract][Full Text] [Related]
2. Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.
Levy-Shraga Y; Lerner-Geva L; Modan-Moses D; Graph-Barel C; Mazor-Aronovitch K; Boyko V; Pinhas-Hamiel O
Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):225-9. PubMed ID: 23329580
[TBL] [Abstract][Full Text] [Related]
3. [Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus].
Hasselmann C; Bonnemaison E; Faure N; Mercat I; Bouillo Pépin-Donat M; Magontier N; Chantepie A; Labarthe F
Arch Pediatr; 2012 Jun; 19(6):593-8. PubMed ID: 22584198
[TBL] [Abstract][Full Text] [Related]
4. Insulin pumps and continuous glucose monitoring (CGM) in preschool and school-age children: how schools can integrate technology.
Bratina N; Battelino T
Pediatr Endocrinol Rev; 2010 Aug; 7 Suppl 3():417-21. PubMed ID: 20877256
[TBL] [Abstract][Full Text] [Related]
5. Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion.
Patton SR; Dolan LM; Henry R; Powers SW
Pediatr Diabetes; 2007 Dec; 8(6):362-8. PubMed ID: 18036061
[TBL] [Abstract][Full Text] [Related]
6. Psychological impact of continuous subcutaneous insulin infusion pump therapy in non-selected newly diagnosed insulin dependent (type 1) diabetic children: evaluation after two years of therapy.
Slijper FM; De Beaufort CE; Bruining GJ; De Visser JJ; Aarsen RS; Kicken DA; Van Strik R
Diabete Metab; 1990; 16(4):273-7. PubMed ID: 2265733
[TBL] [Abstract][Full Text] [Related]
7. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
Eugster EA; Francis G;
Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
[TBL] [Abstract][Full Text] [Related]
8. Identifying the special needs of children with Type 1 diabetes in the school setting. An overview of parents' perceptions.
Amillategui B; Calle JR; Alvarez MA; Cardiel MA; Barrio R
Diabet Med; 2007 Oct; 24(10):1073-9. PubMed ID: 17888130
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study.
Berhe T; Postellon D; Wilson B; Stone R
Pediatrics; 2006 Jun; 117(6):2132-7. PubMed ID: 16740857
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
[TBL] [Abstract][Full Text] [Related]
11. [Does insulin pump therapy improve quality of life and satisfaction in children and adolescents with type 1 diabetes?].
Lichtenberger-Geslin L; Boudailliez B; Braun K; Bach V; Mercier A; Bony-Trifunovic H
Arch Pediatr; 2013 Mar; 20(3):248-56. PubMed ID: 23380034
[TBL] [Abstract][Full Text] [Related]
12. The management of type 1 diabetes in Australian primary schools.
Marks A; Wilson V; Crisp J
Issues Compr Pediatr Nurs; 2014 Sep; 37(3):168-82. PubMed ID: 25007139
[TBL] [Abstract][Full Text] [Related]
13. Dermatological side effects and complications of continuous subcutaneous insulin infusion in preschool-age and school-age children.
Schober E; Rami B
Pediatr Diabetes; 2009 May; 10(3):198-201. PubMed ID: 19175897
[TBL] [Abstract][Full Text] [Related]
14. Investigation of quality of life and family burden issues during insulin pump therapy in children with Type 1 diabetes mellitus--a large-scale multicentre pilot study.
Müller-Godeffroy E; Treichel S; Wagner VM;
Diabet Med; 2009 May; 26(5):493-501. PubMed ID: 19646189
[TBL] [Abstract][Full Text] [Related]
15. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
16. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus.
Opipari-Arrigan L; Fredericks EM; Burkhart N; Dale L; Hodge M; Foster C
Pediatr Diabetes; 2007 Dec; 8(6):377-83. PubMed ID: 18036064
[TBL] [Abstract][Full Text] [Related]
17. Special needs of children with type 1 diabetes at primary school: perceptions from parents, children, and teachers.
Amillategui B; Mora E; Calle JR; Giralt P
Pediatr Diabetes; 2009 Feb; 10(1):67-73. PubMed ID: 18761643
[TBL] [Abstract][Full Text] [Related]
18. A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries.
Danne T; Battelino T; Kordonouri O; Hanas R; Klinkert C; Ludvigsson J; Barrio R; Aebi C; Gschwend S; Mullis PE; Schumacher U; Zumsteg U; Morandi A; Rabbone I; Cherubini V; Toni S; de Beaufort C; Hindmarsh P; Sumner A; van Waarde WM; van den Berg N; Phillip M
Pediatr Diabetes; 2005 Dec; 6(4):193-8. PubMed ID: 16390387
[TBL] [Abstract][Full Text] [Related]
19. The use of Continuous Subcutaneous Insulin Infusion (CSII): parental and professional perceptions of self-care mastery and autonomy in children and adolescents.
Weissberg-Benchell J; Goodman SS; Antisdel Lomaglio J; Zebracki K
J Pediatr Psychol; 2007; 32(10):1196-202. PubMed ID: 17599966
[TBL] [Abstract][Full Text] [Related]
20. The experiences of school nurses caring for students receiving continuous subcutaneous insulin infusion therapy.
Darby W
J Sch Nurs; 2006 Dec; 22(6):336-44. PubMed ID: 17121444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
